Approval · Notice of Compliance 511 · 2002
GEN-FLUCONAZOLE: Notice of Compliance 511
Issued June 5, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 511
- Date
- June 5, 2002
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antifungal agent
- Canadian reference product
- DIFLUCAN 100 MG (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-FLUCONAZOLE | 02245292 | Marketed |
| GEN-FLUCONAZOLE | 02245293 | Marketed |
| GEN-FLUCONAZOLE | 02245294 | — |
Medicinal ingredients
- FLUCONAZOLE 50 MG per TAB
- FLUCONAZOLE 100 MG per TAB
- FLUCONAZOLE 200 MG per TAB